NOX 1.52% 6.7¢ noxopharm limited

Ann: Veyonda and Opdivo IONIC Study First Patient Dosed, page-12

  1. 424 Posts.
    lightbulb Created with Sketch. 206
    Bristol Myers adds to neoadjuvant win for Opdivo in lung cancer, escalating early cancer showdown with Merck – Endpoints News (endpts.com)

    NOX is a while off knowing if IONIC is a success but its nice to think about what would happen to the share price if Veyonda shows itself to be the catalyst for increased efficacy of PD-(L)1 inhibitors. What would BMS pay to get out well ahead of keytruda?
    Last edited by couldwellb: 09/11/21
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.7¢
Change
0.001(1.52%)
Mkt cap ! $19.57M
Open High Low Value Volume
6.7¢ 6.7¢ 6.7¢ $818 12.21K

Buyers (Bids)

No. Vol. Price($)
1 17790 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 4049 1
View Market Depth
Last trade - 15.44pm 12/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.